SBIR-STTR Award

Bioluminscence Assay for Gene Expression Analysis
Award last edited on: 6/4/09

Sponsored Program
SBIR
Awarding Agency
NIH : NIGMS
Total Award Amount
$828,798
Award Phase
2
Solicitation Topic Code
-----

Principal Investigator
Valerie V Golovlev

Company Information

Aurogene Life Science (AKA: Sci-Tec Inc)

156 Fairbanks Road
Oak Ridge, TN 37830
   (865) 275-5800
   sales@aurogene.com
   www.aurogene.com
Location: Single
Congr. District: 03
County: Anderson

Phase I

Contract Number: 1R43GM080037-01
Start Date: 9/30/06    Completed: 3/31/07
Phase I year
2006
Phase I Amount
$100,000
The goal of this project is to develop a new highly sensitive and cost effective Reverse Transcription Quantitative Bioluminescence Assay (RT-qBLA) for high-throughput detection and quantification of large (mRNA) and small (microRNA) RNAs in diverse biological samples. The RT-qBLA implements the same detection concept known from pyrosequencing, yet expanding pyrosequencing detection methodology for highly sensitive and accurate quantification of RNA molecules for gene expression analysis. The proposed assay can successfully challenge the real time quantitative RT-PCR technique (RT-qPCR) in many applications and can be superior to RT-qPCR particularly for the analysis of small RNA molecules. The RT-qBLA is requiring less expensive reagents and equipment and can be used in a number of commercial assays for application in life sciences research, drug discovery, clinical diagnosis, environmental analysis, and biodefense. The goal of this project is to develop a new high performance cost effective bioluminescence assay for gene expression analysis. The proposed assay provides technologically advanced and significantly less expensive alternative for real time polymerase chain reaction technology, which currently dominates in the market. The proposed bioluminescent assay is universal and can be used in various applications in life science research, drug discovery, clinical diagnosis and biodefense in more than 1,800 clinical laboratories and thousands of life science research laboratories in US.

Thesaurus Terms:
Bioassay, Bioluminescence, Gene Expression Profiling, Method Development, Nucleic Acid Quantitation /Detection Cost Effectiveness, Messenger Rna, Microrna, Pyrophosphate Bioengineering /Biomedical Engineering, Clinical Research, Polymerase Chain Reaction

Phase II

Contract Number: 2R44GM080037-02
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
2008
(last award dollars: 2009)
Phase II Amount
$728,798

The goal of this project is to develop a new highly sensitive and cost effective RNA Bioluminescent Assay (RT-qBLA) for high-throughput detection and quantification of RNA and DNA in biological samples. The assay implements the same detection concept known from pyrosequencing, yet expanding pyrosequencing methodology for highly sensitive and accurate quantification of RNA and DNA molecules. The proposed assay has unique sensitivity and dynamic range and is able to measure kinetics of RNA and DNA replication in the solution in real time without long and expensive sample amplification of the real time PCR. The RT-qBLA requires less expensive reagents and equipment than real time PCR and DNA microarrays and can be used in a various commercial assays in life sciences research, drug discovery, and clinical diagnosis.

Public Health Relevance:
This Public Health Relevance is not available.

Thesaurus Terms:
There Are No Thesaurus Terms On File For This Project.